Business
Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion
FREEHOLD, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced a series of Q3 2025 advancements for KetoAir™, including expanded deployment, the launch of a first-responder metabolic health program, and entry into an international market. Key Highlights Launched Holistic Health Reset Program with First Responders in NevadaIn August 2025, Avalon, together with Saga Health a
About this update from Avalon Globocare Corp.
[{"type":"image","alt":"Avalon GloboCare Corp.","displaySize":"","headline":null,"caption":"Avalon GloboCare Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":79,"url":"https://media.zenfs.com/en/globenewswire.com/ca14a367dd280e883fb2c073629a950a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/f2z2WLiGU9diHcPeWDzacQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExMTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ca14a367dd280e883fb2c073629a950a","width":300,"height":79}},"lazy":false},{"type":"text","content":"FREEHOLD, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced a series of Q3 2025 advancements for KetoAir™, including expanded deployment, the launch of a first-responder metabolic health program, and entry into an international market.","length":363,"tagName":"p"},{"type":"text","content":"Key Highlights","length":14,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Launched Holistic Health Reset Program with First Responders in NevadaIn August 2025, Avalon, together with Saga Health and SpecialtyHealth, Inc., launched the “Nevada POOL/PACT Holistic Health Reset” program for 50 first responders. The four-month wellness initiative targets metabolic, physical, and behavioral health improvements, supported by mutual accountability and structured guidance. Participants are using KetoAir™ for continuous daily monitoring of metabolic changes, helping them stay engaged and track progress throughout the program.","length":549,"tagName":"p"}]},{"val":[{"type":"text","content":"UK Launch of KetoAir™ Breathalyzer for Distribution and SalesOn September 1, 2025, Avalon began offering its FDA-registered breathalyzer device, KetoAir™, for purchase in the United Kingdom via www.KetoAir.uk. This milestone marks Avalon’s first international expansion of its marketing of the KetoAir™.","length":304,"tagName":"p"}]},{"val":[{"type":"text","content":"KetoAir™ Showcased at London Health Optimization SummitAvalon presented KetoAir™ at the two-day London Health Optimization Summit on September 13th and 14th, 2025. During the event, attendees learned firsthand how KetoAir™ integrates into broader wellness and metabolic-health programs.","length":287,"tagName":"p"}]},{"val":[{"type"...